Clinical Trial

Aquamin® as an Adjuvant Intervention for Ulcerative Colitis

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine if Aquamin® works as a potential treatment to improve symptoms and if it will induce remission in patients with mild Ulcerative Colitis and extend remission in Ulcerative Colitis in remission.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2019-03-08; most recent amendment 2026-01-15.
Status change: Recruiting → Active, Not Recruiting 2024-07-26
Status change: Not Yet Recruiting → Recruiting 2019-08-07
Trial Details
NCT Number NCT03869905
Lead Sponsor Muhammad N Aslam, MD
Conditions Ulcerative Colitis
Enrollment 40 participants
Start Date 2019-08-08
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-20